Specifically, 76.9% (10 out of 13) of cancer signalling hallmarks exhibited back‐splicing activity in at least half of the GBC samples, such as ‘KRAS signalling’ and ‘Hedgehog signalling’. This evidence concerns the gene KRAS and cancer.